JP2014521711A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014521711A5 JP2014521711A5 JP2014524387A JP2014524387A JP2014521711A5 JP 2014521711 A5 JP2014521711 A5 JP 2014521711A5 JP 2014524387 A JP2014524387 A JP 2014524387A JP 2014524387 A JP2014524387 A JP 2014524387A JP 2014521711 A5 JP2014521711 A5 JP 2014521711A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridin
- pyrazolo
- pyrazol
- pyridine
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 azetidinyl Azepanyl Chemical group 0.000 claims description 129
- 125000001072 heteroaryl group Chemical group 0.000 claims description 35
- 125000000623 heterocyclic group Chemical group 0.000 claims description 35
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 28
- 150000001875 compounds Chemical class 0.000 claims description 23
- 125000002947 alkylene group Chemical group 0.000 claims description 15
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 125000004452 carbocyclyl group Chemical group 0.000 claims description 8
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 8
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 8
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 8
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 8
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 8
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 8
- 125000001064 morpholinomethyl group Chemical group [H]C([H])(*)N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 claims description 8
- 125000003566 oxetanyl group Chemical group 0.000 claims description 8
- 125000004193 piperazinyl group Chemical group 0.000 claims description 8
- 125000003386 piperidinyl group Chemical group 0.000 claims description 8
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 8
- 125000002393 azetidinyl group Chemical group 0.000 claims description 7
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims description 7
- 125000003725 azepanyl group Chemical group 0.000 claims description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000000304 alkynyl group Chemical group 0.000 claims description 2
- 125000005418 aryl aryl group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 241000143392 Oar Species 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- FWMVELRLCYRLLJ-CVEARBPZSA-N (1S,3R)-1-N-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]cyclohexane-1,3-diamine Chemical compound C1[C@H](N)CCC[C@@H]1NC1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=N1 FWMVELRLCYRLLJ-CVEARBPZSA-N 0.000 claims 2
- 208000008787 Cardiovascular Disease Diseases 0.000 claims 2
- 206010021425 Immune system disease Diseases 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 102000030951 Phosphotransferases Human genes 0.000 claims 2
- 108091000081 Phosphotransferases Proteins 0.000 claims 2
- 206010047461 Viral infection Diseases 0.000 claims 2
- 208000001756 Virus Disease Diseases 0.000 claims 2
- BJJPPPDXUHMCKM-UHFFFAOYSA-N [1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]-1,4-diazepan-6-yl]methanol Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CC(CO)CNCC2)=N1 BJJPPPDXUHMCKM-UHFFFAOYSA-N 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 230000002124 endocrine Effects 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000002503 metabolic Effects 0.000 claims 2
- 230000000926 neurological Effects 0.000 claims 2
- 230000017613 viral reproduction Effects 0.000 claims 2
- FWMVELRLCYRLLJ-JKSUJKDBSA-N (1R,3S)-1-N-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]cyclohexane-1,3-diamine Chemical compound C1[C@@H](N)CCC[C@H]1NC1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=N1 FWMVELRLCYRLLJ-JKSUJKDBSA-N 0.000 claims 1
- RCULPSICDMRUIS-CQSZACIVSA-N (3R)-1-[3-bromo-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidin-3-amine Chemical compound C1[C@H](N)CCCN1C1=NC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=CC=C1Br RCULPSICDMRUIS-CQSZACIVSA-N 0.000 claims 1
- OJUHXQHKLKXSGG-CYBMUJFWSA-N (3R)-1-[3-bromo-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]pyrrolidin-3-amine Chemical compound C1[C@H](N)CCN1C1=NC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=CC=C1Br OJUHXQHKLKXSGG-CYBMUJFWSA-N 0.000 claims 1
- SIUHZXBMKPIEBR-CQSZACIVSA-N (3R)-1-[3-bromo-6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(Br)C(N2C[C@H](N)CCC2)=N1 SIUHZXBMKPIEBR-CQSZACIVSA-N 0.000 claims 1
- FPAAQGFYCYLQTR-CYBMUJFWSA-N (3R)-1-[3-bromo-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-ol Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(Br)C(N2C[C@H](O)CCC2)=N1 FPAAQGFYCYLQTR-CYBMUJFWSA-N 0.000 claims 1
- YWLVRWOOKKXPLZ-MRXNPFEDSA-N (3R)-1-[3-methyl-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidin-3-amine Chemical compound CC1=CC=C(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)N=C1N1CCC[C@@H](N)C1 YWLVRWOOKKXPLZ-MRXNPFEDSA-N 0.000 claims 1
- UTZIYQNSLAYKSK-OAHLLOKOSA-N (3R)-1-[3-methyl-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]pyrrolidin-3-amine Chemical compound CC1=CC=C(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)N=C1N1CC[C@@H](N)C1 UTZIYQNSLAYKSK-OAHLLOKOSA-N 0.000 claims 1
- QQLMYTBQUSPVAD-OAHLLOKOSA-N (3R)-1-[3-methyl-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-ol Chemical compound CC1=CC=C(C=2C3=CC(=NC=C3NN=2)C2=CN(C)N=C2)N=C1N1CCC[C@@H](O)C1 QQLMYTBQUSPVAD-OAHLLOKOSA-N 0.000 claims 1
- INCYFYOAJSQBCO-CYBMUJFWSA-N (3R)-1-[4-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyrimidin-2-yl]piperidin-3-amine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=NC(N2C[C@H](N)CCC2)=N1 INCYFYOAJSQBCO-CYBMUJFWSA-N 0.000 claims 1
- CRTGBXQFOHCYKB-CYBMUJFWSA-N (3R)-1-[6-(5-imidazol-1-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidin-3-amine Chemical compound C1[C@H](N)CCCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)N2C=NC=C2)=N1 CRTGBXQFOHCYKB-CYBMUJFWSA-N 0.000 claims 1
- AUGGRGUVEXOOJJ-CYBMUJFWSA-N (3R)-1-[6-[3-(2-fluorophenyl)-1H-pyrazolo[3,4-c]pyridin-5-yl]pyrazin-2-yl]piperidin-3-amine Chemical compound C1[C@H](N)CCCN1C1=CN=CC(C=2N=CC=3NN=C(C=3C=2)C=2C(=CC=CC=2)F)=N1 AUGGRGUVEXOOJJ-CYBMUJFWSA-N 0.000 claims 1
- SGNDEKTYVWRLGA-MRXNPFEDSA-N (3R)-1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]-3-methylpyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(C)C(N2C[C@H](N)CCC2)=N1 SGNDEKTYVWRLGA-MRXNPFEDSA-N 0.000 claims 1
- IUPXPASTCFUQOD-JOCHJYFZSA-N (3R)-1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]-3-methylpiperidin-3-ol Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@](C)(O)CCC2)=N1 IUPXPASTCFUQOD-JOCHJYFZSA-N 0.000 claims 1
- XOFPWIBJTONLMF-MRXNPFEDSA-N (3R)-1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]-N-methylpiperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@@H](CCC2)NC)=N1 XOFPWIBJTONLMF-MRXNPFEDSA-N 0.000 claims 1
- KBYQJTFOVSYTAY-OAHLLOKOSA-N (3R)-1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@H](N)CCC2)=N1 KBYQJTFOVSYTAY-OAHLLOKOSA-N 0.000 claims 1
- BVCAGJZNPVSGFU-OAHLLOKOSA-N (3R)-1-[6-[5-(5-fluoropyridin-3-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound C1[C@H](N)CCCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=C(F)C=NC=2)=N1 BVCAGJZNPVSGFU-OAHLLOKOSA-N 0.000 claims 1
- PIKYKNBWDFZDPW-OAQYLSRUSA-N (3R)-3-methyl-1-[6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-ol Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@](C)(O)CCC2)=N1 PIKYKNBWDFZDPW-OAQYLSRUSA-N 0.000 claims 1
- BUCZZJIVGARTQA-HZPDHXFCSA-N (3R,4R)-1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]-4-fluoropiperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@@H](N)[C@H](F)CC2)=N1 BUCZZJIVGARTQA-HZPDHXFCSA-N 0.000 claims 1
- BHBWYOGZMWLUSZ-ZIAGYGMSSA-N (3R,5R)-1-[3-bromo-6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]-5-fluoropiperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(Br)C(N2C[C@H](F)C[C@@H](N)C2)=N1 BHBWYOGZMWLUSZ-ZIAGYGMSSA-N 0.000 claims 1
- WYNXSGCLOVESGX-ZIAGYGMSSA-N (3R,5R)-5-fluoro-1-[6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@H](F)C[C@@H](N)C2)=N1 WYNXSGCLOVESGX-ZIAGYGMSSA-N 0.000 claims 1
- RCULPSICDMRUIS-AWEZNQCLSA-N (3S)-1-[3-bromo-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidin-3-amine Chemical compound C1[C@@H](N)CCCN1C1=NC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=CC=C1Br RCULPSICDMRUIS-AWEZNQCLSA-N 0.000 claims 1
- SIUHZXBMKPIEBR-AWEZNQCLSA-N (3S)-1-[3-bromo-6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(Br)C(N2C[C@@H](N)CCC2)=N1 SIUHZXBMKPIEBR-AWEZNQCLSA-N 0.000 claims 1
- GFRXZJASIHLAME-ZDUSSCGKSA-N (3S)-1-[3-bromo-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(Br)C(N2C[C@@H](N)CCC2)=N1 GFRXZJASIHLAME-ZDUSSCGKSA-N 0.000 claims 1
- FPAAQGFYCYLQTR-ZDUSSCGKSA-N (3S)-1-[3-bromo-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-ol Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(Br)C(N2C[C@@H](O)CCC2)=N1 FPAAQGFYCYLQTR-ZDUSSCGKSA-N 0.000 claims 1
- ORMLAAJINVYSDT-AWEZNQCLSA-N (3S)-1-[3-chloro-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidin-3-amine Chemical compound C1[C@@H](N)CCCN1C1=NC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=CC=C1Cl ORMLAAJINVYSDT-AWEZNQCLSA-N 0.000 claims 1
- DYZILEJNHNIIPT-KRWDZBQOSA-N (3S)-1-[3-cyclopropyl-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidin-3-amine Chemical compound C1[C@@H](N)CCCN1C1=NC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=CC=C1C1CC1 DYZILEJNHNIIPT-KRWDZBQOSA-N 0.000 claims 1
- YRXJFWBWHWPJIZ-KRWDZBQOSA-N (3S)-1-[3-cyclopropyl-6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C(N=C1N2C[C@@H](N)CCC2)=CC=C1C1CC1 YRXJFWBWHWPJIZ-KRWDZBQOSA-N 0.000 claims 1
- YSENKVFQIMKERQ-INIZCTEOSA-N (3S)-1-[3-cyclopropyl-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C(N=C1N2C[C@@H](N)CCC2)=CC=C1C1CC1 YSENKVFQIMKERQ-INIZCTEOSA-N 0.000 claims 1
- LNLNEGVDDONWAH-KRWDZBQOSA-N (3S)-1-[3-ethenyl-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidin-3-amine Chemical compound C1[C@@H](N)CCCN1C1=NC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=CC=C1C=C LNLNEGVDDONWAH-KRWDZBQOSA-N 0.000 claims 1
- KSMBRINTVBRFFH-KRWDZBQOSA-N (3S)-1-[3-ethenyl-6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(C=C)C(N2C[C@@H](N)CCC2)=N1 KSMBRINTVBRFFH-KRWDZBQOSA-N 0.000 claims 1
- KTVHKYSCYWWSBH-INIZCTEOSA-N (3S)-1-[3-ethenyl-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(C=C)C(N2C[C@@H](N)CCC2)=N1 KTVHKYSCYWWSBH-INIZCTEOSA-N 0.000 claims 1
- MCRHVULASBRJTF-KRWDZBQOSA-N (3S)-1-[3-ethyl-6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound CCC1=CC=C(C=2C3=CC(=NC=C3NN=2)C2=CN(CC)N=C2)N=C1N1CCC[C@H](N)C1 MCRHVULASBRJTF-KRWDZBQOSA-N 0.000 claims 1
- FECWDXPJMOSNMV-INIZCTEOSA-N (3S)-1-[3-ethyl-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound CCC1=CC=C(C=2C3=CC(=NC=C3NN=2)C2=CN(C)N=C2)N=C1N1CCC[C@H](N)C1 FECWDXPJMOSNMV-INIZCTEOSA-N 0.000 claims 1
- YWLVRWOOKKXPLZ-INIZCTEOSA-N (3S)-1-[3-methyl-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidin-3-amine Chemical compound CC1=CC=C(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)N=C1N1CCC[C@H](N)C1 YWLVRWOOKKXPLZ-INIZCTEOSA-N 0.000 claims 1
- UTZIYQNSLAYKSK-HNNXBMFYSA-N (3S)-1-[3-methyl-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]pyrrolidin-3-amine Chemical compound CC1=CC=C(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)N=C1N1CC[C@H](N)C1 UTZIYQNSLAYKSK-HNNXBMFYSA-N 0.000 claims 1
- XWOSSDMMJDYDBX-HNNXBMFYSA-N (3S)-1-[3-methyl-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound CC1=CC=C(C=2C3=CC(=NC=C3NN=2)C2=CN(C)N=C2)N=C1N1CCC[C@H](N)C1 XWOSSDMMJDYDBX-HNNXBMFYSA-N 0.000 claims 1
- QQLMYTBQUSPVAD-HNNXBMFYSA-N (3S)-1-[3-methyl-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-ol Chemical compound CC1=CC=C(C=2C3=CC(=NC=C3NN=2)C2=CN(C)N=C2)N=C1N1CCC[C@H](O)C1 QQLMYTBQUSPVAD-HNNXBMFYSA-N 0.000 claims 1
- FEMLZOWSASZDMK-KRWDZBQOSA-N (3S)-1-[3-prop-1-en-2-yl-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidin-3-amine Chemical compound CC(=C)C1=CC=C(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)N=C1N1CCC[C@H](N)C1 FEMLZOWSASZDMK-KRWDZBQOSA-N 0.000 claims 1
- VGJWLOJQVWBUSL-KRWDZBQOSA-N (3S)-1-[3-propan-2-yl-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidin-3-amine Chemical compound CC(C)C1=CC=C(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)N=C1N1CCC[C@H](N)C1 VGJWLOJQVWBUSL-KRWDZBQOSA-N 0.000 claims 1
- INCYFYOAJSQBCO-ZDUSSCGKSA-N (3S)-1-[4-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyrimidin-2-yl]piperidin-3-amine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=NC(N2C[C@@H](N)CCC2)=N1 INCYFYOAJSQBCO-ZDUSSCGKSA-N 0.000 claims 1
- WIBSDSHYWJBRSJ-AWEZNQCLSA-N (3S)-1-[5-chloro-6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=NC(N2C[C@@H](N)CCC2)=CC=C1Cl WIBSDSHYWJBRSJ-AWEZNQCLSA-N 0.000 claims 1
- CRTGBXQFOHCYKB-ZDUSSCGKSA-N (3S)-1-[6-(5-imidazol-1-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidin-3-amine Chemical compound C1[C@@H](N)CCCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)N2C=NC=C2)=N1 CRTGBXQFOHCYKB-ZDUSSCGKSA-N 0.000 claims 1
- UIQIHRNBPQGQQH-AWEZNQCLSA-N (3S)-1-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)-3-(trifluoromethyl)pyridin-2-yl]piperidin-3-amine Chemical compound C1[C@@H](N)CCCN1C1=NC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=CC=C1C(F)(F)F UIQIHRNBPQGQQH-AWEZNQCLSA-N 0.000 claims 1
- RDFCHPVWLJDNIJ-AWEZNQCLSA-N (3S)-1-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]pyrrolidin-3-amine Chemical compound C1[C@@H](N)CCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=N1 RDFCHPVWLJDNIJ-AWEZNQCLSA-N 0.000 claims 1
- AUGGRGUVEXOOJJ-ZDUSSCGKSA-N (3S)-1-[6-[3-(2-fluorophenyl)-1H-pyrazolo[3,4-c]pyridin-5-yl]pyrazin-2-yl]piperidin-3-amine Chemical compound C1[C@@H](N)CCCN1C1=CN=CC(C=2N=CC=3NN=C(C=3C=2)C=2C(=CC=CC=2)F)=N1 AUGGRGUVEXOOJJ-ZDUSSCGKSA-N 0.000 claims 1
- YSYVRFJJFUKXNR-LBPRGKRZSA-N (3S)-1-[6-[3-(2-fluorophenyl)-1H-pyrazolo[3,4-c]pyridin-5-yl]pyrazin-2-yl]pyrrolidin-3-amine Chemical compound C1[C@@H](N)CCN1C1=CN=CC(C=2N=CC=3NN=C(C=3C=2)C=2C(=CC=CC=2)F)=N1 YSYVRFJJFUKXNR-LBPRGKRZSA-N 0.000 claims 1
- SGNDEKTYVWRLGA-INIZCTEOSA-N (3S)-1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]-3-methylpyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(C)C(N2C[C@@H](N)CCC2)=N1 SGNDEKTYVWRLGA-INIZCTEOSA-N 0.000 claims 1
- BQBYYZXHZGVJMR-KRWDZBQOSA-N (3S)-1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]-3-prop-1-en-2-ylpyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(C(C)=C)C(N2C[C@@H](N)CCC2)=N1 BQBYYZXHZGVJMR-KRWDZBQOSA-N 0.000 claims 1
- RBCUQLJADFRREM-KRWDZBQOSA-N (3S)-1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]-3-propan-2-ylpyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(C(C)C)C(N2C[C@@H](N)CCC2)=N1 RBCUQLJADFRREM-KRWDZBQOSA-N 0.000 claims 1
- IUPXPASTCFUQOD-QFIPXVFZSA-N (3S)-1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]-3-methylpiperidin-3-ol Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@@](C)(O)CCC2)=N1 IUPXPASTCFUQOD-QFIPXVFZSA-N 0.000 claims 1
- XOFPWIBJTONLMF-INIZCTEOSA-N (3S)-1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]-N-methylpiperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@H](CCC2)NC)=N1 XOFPWIBJTONLMF-INIZCTEOSA-N 0.000 claims 1
- KBYQJTFOVSYTAY-HNNXBMFYSA-N (3S)-1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@@H](N)CCC2)=N1 KBYQJTFOVSYTAY-HNNXBMFYSA-N 0.000 claims 1
- XNXVZMDFPQJZOY-INIZCTEOSA-N (3S)-1-[6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]-3-prop-1-en-2-ylpyridin-2-yl]piperidin-3-amine Chemical compound CC(=C)C1=CC=C(C=2C3=CC(=NC=C3NN=2)C2=CN(C)N=C2)N=C1N1CCC[C@H](N)C1 XNXVZMDFPQJZOY-INIZCTEOSA-N 0.000 claims 1
- OBGMBNNSDGIRFJ-INIZCTEOSA-N (3S)-1-[6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]-3-propan-2-ylpyridin-2-yl]piperidin-3-amine Chemical compound CC(C)C1=CC=C(C=2C3=CC(=NC=C3NN=2)C2=CN(C)N=C2)N=C1N1CCC[C@H](N)C1 OBGMBNNSDGIRFJ-INIZCTEOSA-N 0.000 claims 1
- UZSKGLPUMSUOBY-AWEZNQCLSA-N (3S)-1-[6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@@H](N)CCC2)=N1 UZSKGLPUMSUOBY-AWEZNQCLSA-N 0.000 claims 1
- BVCAGJZNPVSGFU-HNNXBMFYSA-N (3S)-1-[6-[5-(5-fluoropyridin-3-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound C1[C@@H](N)CCCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=C(F)C=NC=2)=N1 BVCAGJZNPVSGFU-HNNXBMFYSA-N 0.000 claims 1
- UCDTVUPIWRMUQR-AWEZNQCLSA-N (3S)-3-amino-1-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]pyrrolidin-2-one Chemical compound O=C1[C@@H](N)CCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=N1 UCDTVUPIWRMUQR-AWEZNQCLSA-N 0.000 claims 1
- PIKYKNBWDFZDPW-NRFANRHFSA-N (3S)-3-methyl-1-[6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-ol Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@@](C)(O)CCC2)=N1 PIKYKNBWDFZDPW-NRFANRHFSA-N 0.000 claims 1
- BHBWYOGZMWLUSZ-KGLIPLIRSA-N (3S,5R)-1-[3-bromo-6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]-5-fluoropiperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(Br)C(N2C[C@H](F)C[C@H](N)C2)=N1 BHBWYOGZMWLUSZ-KGLIPLIRSA-N 0.000 claims 1
- ZIEHPJPLHNKHPZ-OLZOCXBDSA-N (3S,5R)-1-[3-bromo-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]-5-fluoropiperidin-3-amine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(Br)C(N2C[C@H](F)C[C@H](N)C2)=N1 ZIEHPJPLHNKHPZ-OLZOCXBDSA-N 0.000 claims 1
- PPCHVHGYGZYEPP-CVEARBPZSA-N (3S,5R)-1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]-3-methylpyridin-2-yl]-5-fluoropiperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(C)C(N2C[C@H](F)C[C@H](N)C2)=N1 PPCHVHGYGZYEPP-CVEARBPZSA-N 0.000 claims 1
- HOPGMCWYVDUYNO-CABCVRRESA-N (3S,5R)-1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]-5-fluoropiperidin-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@H](F)C[C@H](N)C2)=N1 HOPGMCWYVDUYNO-CABCVRRESA-N 0.000 claims 1
- LGXKCOCTCFMWHJ-CABCVRRESA-N (3S,5R)-5-fluoro-1-[3-methyl-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound CC1=CC=C(C=2C3=CC(=NC=C3NN=2)C2=CN(C)N=C2)N=C1N1C[C@@H](N)C[C@@H](F)C1 LGXKCOCTCFMWHJ-CABCVRRESA-N 0.000 claims 1
- WEEKHEMGSDJQLC-CABCVRRESA-N (3S,5R)-5-fluoro-1-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidin-3-amine Chemical compound C1[C@@H](N)C[C@@H](F)CN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=N1 WEEKHEMGSDJQLC-CABCVRRESA-N 0.000 claims 1
- WYNXSGCLOVESGX-KGLIPLIRSA-N (3S,5R)-5-fluoro-1-[6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-3-amine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@H](F)C[C@H](N)C2)=N1 WYNXSGCLOVESGX-KGLIPLIRSA-N 0.000 claims 1
- SBESMDFHOZSXSF-UHFFFAOYSA-N (4-aminopiperidin-1-yl)-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]methanone Chemical compound C1CC(N)CCN1C(=O)C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=N1 SBESMDFHOZSXSF-UHFFFAOYSA-N 0.000 claims 1
- JIENEKDVIAAQIC-OAHLLOKOSA-N (4R)-1-[3-bromo-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]azepan-4-amine Chemical compound C1C[C@H](N)CCCN1C1=NC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=CC=C1Br JIENEKDVIAAQIC-OAHLLOKOSA-N 0.000 claims 1
- XEMLZMNENJBYBP-QGZVFWFLSA-N (4R)-1-[3-methyl-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]azepan-4-amine Chemical compound CC1=CC=C(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)N=C1N1CCC[C@@H](N)CC1 XEMLZMNENJBYBP-QGZVFWFLSA-N 0.000 claims 1
- HYWSOTQNDXXXJB-MRXNPFEDSA-N (4R)-1-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]azepan-4-amine Chemical compound C1C[C@H](N)CCCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=N1 HYWSOTQNDXXXJB-MRXNPFEDSA-N 0.000 claims 1
- DYEWIERMHIZZLA-MRXNPFEDSA-N (4R)-1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]azepan-4-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CC[C@H](N)CCC2)=N1 DYEWIERMHIZZLA-MRXNPFEDSA-N 0.000 claims 1
- JUXYREUMIHGZST-OAHLLOKOSA-N (4R)-1-[6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]azepan-4-amine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CC[C@H](N)CCC2)=N1 JUXYREUMIHGZST-OAHLLOKOSA-N 0.000 claims 1
- JIENEKDVIAAQIC-HNNXBMFYSA-N (4S)-1-[3-bromo-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]azepan-4-amine Chemical compound C1C[C@@H](N)CCCN1C1=NC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=CC=C1Br JIENEKDVIAAQIC-HNNXBMFYSA-N 0.000 claims 1
- XEMLZMNENJBYBP-KRWDZBQOSA-N (4S)-1-[3-methyl-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]azepan-4-amine Chemical compound CC1=CC=C(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)N=C1N1CCC[C@H](N)CC1 XEMLZMNENJBYBP-KRWDZBQOSA-N 0.000 claims 1
- BLMDGEGSPQPBNP-OAHLLOKOSA-N (6R)-1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]-1,4-diazepan-6-ol Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@H](O)CNCC2)=N1 BLMDGEGSPQPBNP-OAHLLOKOSA-N 0.000 claims 1
- BLMDGEGSPQPBNP-HNNXBMFYSA-N (6S)-1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]-1,4-diazepan-6-ol Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@@H](O)CNCC2)=N1 BLMDGEGSPQPBNP-HNNXBMFYSA-N 0.000 claims 1
- CEQYRHVPNYLAKA-UHFFFAOYSA-N 1-(3-amino-2,2-dimethylpropyl)-5-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-one Chemical compound C1=CC(=O)N(CC(C)(CN)C)C=C1C1=NNC2=CN=C(C=3C=NC=CC=3)C=C12 CEQYRHVPNYLAKA-UHFFFAOYSA-N 0.000 claims 1
- LSQVHSIKEZMLQX-UHFFFAOYSA-N 1-(piperidin-4-ylmethyl)-3-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)imidazolidin-2-one Chemical compound C1CN(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)C(=O)N1CC1CCNCC1 LSQVHSIKEZMLQX-UHFFFAOYSA-N 0.000 claims 1
- BSOSQKZSTMNSEC-UHFFFAOYSA-N 1-N-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]cyclohexane-1,3-diamine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(NC2CC(N)CCC2)=N1 BSOSQKZSTMNSEC-UHFFFAOYSA-N 0.000 claims 1
- GIWBSVUHLIJMSE-UHFFFAOYSA-N 1-[3-[3-(2-fluorophenyl)-1H-pyrazolo[3,4-c]pyridin-5-yl]pyridin-4-yl]azepan-4-amine Chemical compound C1CC(N)CCCN1C1=CC=NC=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC=C1F GIWBSVUHLIJMSE-UHFFFAOYSA-N 0.000 claims 1
- DFLOMAREWUSYDW-UHFFFAOYSA-N 1-[3-bromo-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidin-4-ol Chemical compound C1CC(O)CCN1C1=NC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=CC=C1Br DFLOMAREWUSYDW-UHFFFAOYSA-N 0.000 claims 1
- YVACBLRXIPFIHT-UHFFFAOYSA-N 1-[3-bromo-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-4-amine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(Br)C(N2CCC(N)CC2)=N1 YVACBLRXIPFIHT-UHFFFAOYSA-N 0.000 claims 1
- IXDIFIPKASFTPV-UHFFFAOYSA-N 1-[3-methyl-6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidin-4-ol Chemical compound CC1=CC=C(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)N=C1N1CCC(O)CC1 IXDIFIPKASFTPV-UHFFFAOYSA-N 0.000 claims 1
- WLUGAYVZEOAUHP-UHFFFAOYSA-N 1-[3-methyl-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-4-amine Chemical compound CC1=CC=C(C=2C3=CC(=NC=C3NN=2)C2=CN(C)N=C2)N=C1N1CCC(N)CC1 WLUGAYVZEOAUHP-UHFFFAOYSA-N 0.000 claims 1
- IMMJLZKQVTXHAY-UHFFFAOYSA-N 1-[5-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-3-yl]piperidin-4-amine Chemical compound C1CC(N)CCN1C1=CN=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=C1 IMMJLZKQVTXHAY-UHFFFAOYSA-N 0.000 claims 1
- HTAYWJMJSJNZEL-UHFFFAOYSA-N 1-[6-[3-(1-methylpyrazol-3-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]pyrazin-2-yl]piperidin-4-amine Chemical compound CN1C=CC(C=2C3=CC(=NC=C3NN=2)C=2N=C(C=NC=2)N2CCC(N)CC2)=N1 HTAYWJMJSJNZEL-UHFFFAOYSA-N 0.000 claims 1
- WBAWFBZASDSEKA-UHFFFAOYSA-N 1-[6-[3-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]pyrazin-2-yl]piperidin-4-amine Chemical compound C1=NN(C)C=C1C1=NNC2=CN=C(C=3N=C(C=NC=3)N3CCC(N)CC3)C=C12 WBAWFBZASDSEKA-UHFFFAOYSA-N 0.000 claims 1
- LNARXJIXHBVOBV-UHFFFAOYSA-N 1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]azepan-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CC(N)CCCC2)=N1 LNARXJIXHBVOBV-UHFFFAOYSA-N 0.000 claims 1
- BXYXJSLIRCVQHH-UHFFFAOYSA-N 1-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]azepan-3-ol Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CC(O)CCCC2)=N1 BXYXJSLIRCVQHH-UHFFFAOYSA-N 0.000 claims 1
- JYVYFFTYRRBLNY-UHFFFAOYSA-N 1-[6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]-3-(trifluoromethyl)pyrrolidin-3-amine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CC(N)(CC2)C(F)(F)F)=N1 JYVYFFTYRRBLNY-UHFFFAOYSA-N 0.000 claims 1
- GZYQOEDEZRBOFO-UHFFFAOYSA-N 1-[6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]azepan-3-amine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CC(N)CCCC2)=N1 GZYQOEDEZRBOFO-UHFFFAOYSA-N 0.000 claims 1
- JUXYREUMIHGZST-UHFFFAOYSA-N 1-[6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]azepan-4-amine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCC(N)CCC2)=N1 JUXYREUMIHGZST-UHFFFAOYSA-N 0.000 claims 1
- XXEBBXOTFNCOMU-UHFFFAOYSA-N 1-[6-[5-[1-(2-fluoroethyl)pyrazol-4-yl]-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]azepan-3-amine Chemical compound C1C(N)CCCCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C2=CN(CCF)N=C2)=N1 XXEBBXOTFNCOMU-UHFFFAOYSA-N 0.000 claims 1
- ZHZPKKRZEWPEKA-UHFFFAOYSA-N 1-methyl-4-[3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]pyridin-2-one Chemical compound O=C1N(C)C=CC(C=2N=CC=3NN=C(C=3C=2)C=2N=C(C=CC=2)N2CCNCC2)=C1 ZHZPKKRZEWPEKA-UHFFFAOYSA-N 0.000 claims 1
- XDYMUBVABLEPLQ-UHFFFAOYSA-N 2-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridine-4-carboxamide Chemical compound NC(=O)C1=CC=NC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=C1 XDYMUBVABLEPLQ-UHFFFAOYSA-N 0.000 claims 1
- FDUVDOYSKNJROE-UHFFFAOYSA-N 2-[1-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]pyrrolidin-3-yl]ethanamine Chemical compound C1C(CCN)CCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=N1 FDUVDOYSKNJROE-UHFFFAOYSA-N 0.000 claims 1
- HTIXDHPEQICXCW-UHFFFAOYSA-N 2-[4-[3-(6-fluoropyridin-2-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]pyrazol-1-yl]acetamide Chemical compound C1=NN(CC(=O)N)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(F)=N1 HTIXDHPEQICXCW-UHFFFAOYSA-N 0.000 claims 1
- SVYHADKWCWQANW-UHFFFAOYSA-N 2-[4-[3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]pyrazol-1-yl]acetonitrile Chemical compound C1=NN(CC#N)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCNCC2)=N1 SVYHADKWCWQANW-UHFFFAOYSA-N 0.000 claims 1
- YKHRTOSUKCHRDX-UHFFFAOYSA-N 2-[4-[3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]pyrazol-1-yl]ethanol Chemical compound C1=NN(CCO)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCNCC2)=N1 YKHRTOSUKCHRDX-UHFFFAOYSA-N 0.000 claims 1
- VUOHFWGWDSKYMI-UHFFFAOYSA-N 2-[4-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperazin-1-yl]ethanol Chemical compound C1CN(CCO)CCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=N1 VUOHFWGWDSKYMI-UHFFFAOYSA-N 0.000 claims 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims 1
- QEOHCRBBBDTECB-UHFFFAOYSA-N 2-methyl-1-[4-[3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]pyrazol-1-yl]propan-2-ol Chemical compound C1=NN(CC(C)(O)C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCNCC2)=N1 QEOHCRBBBDTECB-UHFFFAOYSA-N 0.000 claims 1
- FYVJFDOSAQFXEE-UHFFFAOYSA-N 3,5-dipyridin-3-yl-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=CN=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=C1 FYVJFDOSAQFXEE-UHFFFAOYSA-N 0.000 claims 1
- YPOSWHJKDVSBFG-UHFFFAOYSA-N 3-(1-piperidin-4-ylpyrazol-3-yl)-5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridine Chemical compound C1CNCCC1N1N=C(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)C=C1 YPOSWHJKDVSBFG-UHFFFAOYSA-N 0.000 claims 1
- HKDNCYDMZJZYGM-UHFFFAOYSA-N 3-(2-fluoro-5-methoxyphenyl)-5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound COC1=CC=C(F)C(C=2C3=CC(=NC=C3NN=2)C2=CN(C)N=C2)=C1 HKDNCYDMZJZYGM-UHFFFAOYSA-N 0.000 claims 1
- BIPWYLAIPQYYIZ-CQSZACIVSA-N 3-(2-fluorophenyl)-5-[4-[[(3R)-pyrrolidin-3-yl]methoxy]pyridin-3-yl]-1H-pyrazolo[3,4-c]pyridine Chemical compound FC1=CC=CC=C1C1=NNC2=CN=C(C=3C(=CC=NC=3)OC[C@H]3CNCC3)C=C12 BIPWYLAIPQYYIZ-CQSZACIVSA-N 0.000 claims 1
- FCRIHMREFBZVTE-HNNXBMFYSA-N 3-(2-fluorophenyl)-5-[4-[[(3S)-piperidin-3-yl]methoxy]pyridin-3-yl]-1H-pyrazolo[3,4-c]pyridine Chemical compound FC1=CC=CC=C1C1=NNC2=CN=C(C=3C(=CC=NC=3)OC[C@@H]3CNCCC3)C=C12 FCRIHMREFBZVTE-HNNXBMFYSA-N 0.000 claims 1
- UQJXXIUBMVASHR-UHFFFAOYSA-N 3-(4-aminopiperidine-1-carbonyl)-1-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyrrolidin-2-one Chemical compound C1CC(N)CCN1C(=O)C1C(=O)N(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)CC1 UQJXXIUBMVASHR-UHFFFAOYSA-N 0.000 claims 1
- QYONTMXDPFWFPN-UHFFFAOYSA-N 3-(5-bromo-6-piperazin-1-ylpyridin-2-yl)-5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(Br)C(N2CCNCC2)=N1 QYONTMXDPFWFPN-UHFFFAOYSA-N 0.000 claims 1
- CHWFFBDEESOIBC-UHFFFAOYSA-N 3-(6-piperazin-1-ylpyridin-2-yl)-5-(1-propan-2-ylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(C(C)C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCNCC2)=N1 CHWFFBDEESOIBC-UHFFFAOYSA-N 0.000 claims 1
- XKPHITFYRRNWMQ-UHFFFAOYSA-N 3-(6-piperazin-1-ylpyridin-2-yl)-5-(1-propylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CCC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCNCC2)=N1 XKPHITFYRRNWMQ-UHFFFAOYSA-N 0.000 claims 1
- MTNRQWRDLVCYQT-UHFFFAOYSA-N 3-(6-piperazin-1-ylpyridin-2-yl)-5-[1-(2,2,2-trifluoroethyl)pyrazol-4-yl]-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC(F)(F)F)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCNCC2)=N1 MTNRQWRDLVCYQT-UHFFFAOYSA-N 0.000 claims 1
- IQOMPZFXVBSCPB-UHFFFAOYSA-N 3-(6-piperazin-1-ylpyridin-2-yl)-5-[5-(trifluoromethyl)pyridin-3-yl]-1H-pyrazolo[3,4-c]pyridine Chemical compound FC(F)(F)C1=CN=CC(C=2N=CC=3NN=C(C=3C=2)C=2N=C(C=CC=2)N2CCNCC2)=C1 IQOMPZFXVBSCPB-UHFFFAOYSA-N 0.000 claims 1
- ARNZQCZBCDADJH-UHFFFAOYSA-N 3-[3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]-1,3-oxazolidin-2-one Chemical compound O=C1OCCN1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCNCC2)=N1 ARNZQCZBCDADJH-UHFFFAOYSA-N 0.000 claims 1
- IYWFOOCVEDOSQM-UHFFFAOYSA-N 3-[3-(6-piperidin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]-1,3-oxazolidin-2-one Chemical compound O=C1OCCN1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCCCC2)=N1 IYWFOOCVEDOSQM-UHFFFAOYSA-N 0.000 claims 1
- YOTFCVUNNCLPOT-GFCCVEGCSA-N 3-[3-[6-[(3R)-3-aminopiperidin-1-yl]pyridin-2-yl]-1H-pyrazolo[3,4-c]pyridin-5-yl]-1,3-oxazolidin-2-one Chemical compound C1[C@H](N)CCCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)N2C(OCC2)=O)=N1 YOTFCVUNNCLPOT-GFCCVEGCSA-N 0.000 claims 1
- YOTFCVUNNCLPOT-LBPRGKRZSA-N 3-[3-[6-[(3S)-3-aminopiperidin-1-yl]pyridin-2-yl]-1H-pyrazolo[3,4-c]pyridin-5-yl]-1,3-oxazolidin-2-one Chemical compound C1[C@@H](N)CCCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)N2C(OCC2)=O)=N1 YOTFCVUNNCLPOT-LBPRGKRZSA-N 0.000 claims 1
- DSZFEVQABXJNBQ-UHFFFAOYSA-N 3-[5-bromo-6-(4-methylpiperazin-1-yl)pyridin-2-yl]-5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1CN(C)CCN1C1=NC(C=2C3=CC(=NC=C3NN=2)C2=CN(C)N=C2)=CC=C1Br DSZFEVQABXJNBQ-UHFFFAOYSA-N 0.000 claims 1
- BNXCQJKCLBQCJW-UHFFFAOYSA-N 3-[5-bromo-6-[3,3-dimethyl-4-(2-methylsulfonylethyl)piperazin-1-yl]pyridin-2-yl]-5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(Br)C(N2CC(C)(C)N(CCS(C)(=O)=O)CC2)=N1 BNXCQJKCLBQCJW-UHFFFAOYSA-N 0.000 claims 1
- RSRCWMFXYSDZGP-UHFFFAOYSA-N 3-[5-methyl-6-(4-methylpiperazin-1-yl)pyridin-2-yl]-5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1CN(C)CCN1C1=NC(C=2C3=CC(=NC=C3NN=2)C2=CN(C)N=C2)=CC=C1C RSRCWMFXYSDZGP-UHFFFAOYSA-N 0.000 claims 1
- FTCGBSBOZWGTEI-UHFFFAOYSA-N 3-[6-(1,4-diazepan-1-yl)-4-methylpyridin-2-yl]-5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC(C)=CC(N2CCNCCC2)=N1 FTCGBSBOZWGTEI-UHFFFAOYSA-N 0.000 claims 1
- GKVMUEOQUFVJNA-UHFFFAOYSA-N 3-[6-(1,4-diazepan-1-yl)pyridin-2-yl]-5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCNCCC2)=N1 GKVMUEOQUFVJNA-UHFFFAOYSA-N 0.000 claims 1
- DLZIZKARHRLIHL-UHFFFAOYSA-N 3-[6-(1,4-diazepan-1-yl)pyridin-2-yl]-5-[1-(2-fluoroethyl)pyrazol-4-yl]-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CCF)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCNCCC2)=N1 DLZIZKARHRLIHL-UHFFFAOYSA-N 0.000 claims 1
- ASMXGGRPAPHNDN-UHFFFAOYSA-N 3-[6-(3,3-dimethylpiperazin-1-yl)pyridin-2-yl]-5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CC(C)(C)NCC2)=N1 ASMXGGRPAPHNDN-UHFFFAOYSA-N 0.000 claims 1
- UNMSQVAIBXEGPW-UHFFFAOYSA-N 3-[6-(6,6-difluoro-1,4-diazepan-1-yl)pyridin-2-yl]-5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CC(F)(F)CNCC2)=N1 UNMSQVAIBXEGPW-UHFFFAOYSA-N 0.000 claims 1
- LEWYARJFFZCABK-KBPBESRZSA-N 3-[6-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyridin-2-yl]-5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C([C@]1(NC[C@]2([H])C1)[H])N2C(N=1)=CC=CC=1C(C1=C2)=NNC1=CN=C2C=1C=NN(C)C=1 LEWYARJFFZCABK-KBPBESRZSA-N 0.000 claims 1
- XKFCTVWJFCKNBW-GASCZTMLSA-N 3-[6-[(3R,5S)-3,5-dimethylpiperazin-1-yl]pyridin-2-yl]-5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@@H](C)N[C@@H](C)C2)=N1 XKFCTVWJFCKNBW-GASCZTMLSA-N 0.000 claims 1
- HCIXMOJLLZUZRM-UHFFFAOYSA-N 3-[6-[3,3-dimethyl-4-(2-methylsulfonylethyl)piperazin-1-yl]-5-methylpyridin-2-yl]-5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound CC1=CC=C(C=2C3=CC(=NC=C3NN=2)C2=CN(C)N=C2)N=C1N1CCN(CCS(C)(=O)=O)C(C)(C)C1 HCIXMOJLLZUZRM-UHFFFAOYSA-N 0.000 claims 1
- BAUZKJYZGGFFLL-UHFFFAOYSA-N 3-ethyl-5-[3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]pyrimidin-4-one Chemical compound O=C1N(CC)C=NC=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCNCC2)=N1 BAUZKJYZGGFFLL-UHFFFAOYSA-N 0.000 claims 1
- KIBZGUOKQUDIFC-UHFFFAOYSA-N 3-methyl-1-[3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]imidazolidine-2,4-dione Chemical compound O=C1N(C)C(=O)CN1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCNCC2)=N1 KIBZGUOKQUDIFC-UHFFFAOYSA-N 0.000 claims 1
- OBFDCGZSIFTBMR-UHFFFAOYSA-N 3-naphthalen-2-yl-1H-pyrazolo[3,4-c]pyridine-5-carbonitrile Chemical compound C1=CC=CC2=CC(C=3C=4C=C(N=CC=4NN=3)C#N)=CC=C21 OBFDCGZSIFTBMR-UHFFFAOYSA-N 0.000 claims 1
- TYPVALHZTLRMMR-UHFFFAOYSA-N 4-[1-[3-bromo-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]azetidin-3-yl]piperazin-2-one Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(Br)C(N2CC(C2)N2CC(=O)NCC2)=N1 TYPVALHZTLRMMR-UHFFFAOYSA-N 0.000 claims 1
- QGRXFBMPBXBHHN-UHFFFAOYSA-N 4-[1-[3-methyl-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]azetidin-3-yl]piperazin-2-one Chemical compound CC1=CC=C(C=2C3=CC(=NC=C3NN=2)C2=CN(C)N=C2)N=C1N(C1)CC1N1CCNC(=O)C1 QGRXFBMPBXBHHN-UHFFFAOYSA-N 0.000 claims 1
- DYAGKFLCPXLHPV-UHFFFAOYSA-N 4-[3-bromo-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]morpholine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(Br)C(N2CCOCC2)=N1 DYAGKFLCPXLHPV-UHFFFAOYSA-N 0.000 claims 1
- VGXQLRWWQIUSGF-UHFFFAOYSA-N 4-[3-methyl-6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]morpholine Chemical compound CC1=CC=C(C=2C3=CC(=NC=C3NN=2)C2=CN(C)N=C2)N=C1N1CCOCC1 VGXQLRWWQIUSGF-UHFFFAOYSA-N 0.000 claims 1
- MLCXAWAHXUAMQD-UHFFFAOYSA-N 4-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperazin-2-one Chemical compound C1CNC(=O)CN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=N1 MLCXAWAHXUAMQD-UHFFFAOYSA-N 0.000 claims 1
- FORXCJRKNHYUBC-UHFFFAOYSA-N 4-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidin-4-ol Chemical compound C=1C=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=NC=1C1(O)CCNCC1 FORXCJRKNHYUBC-UHFFFAOYSA-N 0.000 claims 1
- FTLPJRYZRTWCHZ-UHFFFAOYSA-N 4-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]morpholine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCOCC2)=N1 FTLPJRYZRTWCHZ-UHFFFAOYSA-N 0.000 claims 1
- JYFODXOVZPQVRW-UHFFFAOYSA-N 4-amino-1-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidine-4-carboxamide Chemical compound C1CC(C(=O)N)(N)CCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=N1 JYFODXOVZPQVRW-UHFFFAOYSA-N 0.000 claims 1
- KQTDCSHMLHQAHE-UHFFFAOYSA-N 4-amino-N-methyl-1-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidine-4-carboxamide Chemical compound C1CC(C(=O)NC)(N)CCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=N1 KQTDCSHMLHQAHE-UHFFFAOYSA-N 0.000 claims 1
- GWYKGOZFKXKMND-UHFFFAOYSA-N 5-(1-cyclobutylpyrazol-4-yl)-3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1CCC1N1N=CC(C=2N=CC=3NN=C(C=3C=2)C=2N=C(C=CC=2)N2CCNCC2)=C1 GWYKGOZFKXKMND-UHFFFAOYSA-N 0.000 claims 1
- BMHDMTOGIQRECR-UHFFFAOYSA-N 5-(1-cyclopropylpyrazol-4-yl)-3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1CC1N1N=CC(C=2N=CC=3NN=C(C=3C=2)C=2N=C(C=CC=2)N2CCNCC2)=C1 BMHDMTOGIQRECR-UHFFFAOYSA-N 0.000 claims 1
- XOYGKHCOPQURQV-UHFFFAOYSA-N 5-(1-ethylpyrazol-4-yl)-3-(4-methoxypyridin-2-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC(OC)=CC=N1 XOYGKHCOPQURQV-UHFFFAOYSA-N 0.000 claims 1
- DXJWSLRIHWJKCO-UHFFFAOYSA-N 5-(1-ethylpyrazol-4-yl)-3-(4-prop-1-en-2-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC(C(C)=C)=CC=N1 DXJWSLRIHWJKCO-UHFFFAOYSA-N 0.000 claims 1
- XMTRMCWKMSOGQR-UHFFFAOYSA-N 5-(1-ethylpyrazol-4-yl)-3-(5-methyl-6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=C(C)C(N2CCNCC2)=N1 XMTRMCWKMSOGQR-UHFFFAOYSA-N 0.000 claims 1
- LYQWUXCDSOKJRT-UHFFFAOYSA-N 5-(1-ethylpyrazol-4-yl)-3-(6-piperazin-1-ylpyrazin-2-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CN=CC(N2CCNCC2)=N1 LYQWUXCDSOKJRT-UHFFFAOYSA-N 0.000 claims 1
- VFXUYKQSTNDXRJ-UHFFFAOYSA-N 5-(1-ethylpyrazol-4-yl)-3-[4-(trifluoromethyl)pyridin-2-yl]-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC(C(F)(F)F)=CC=N1 VFXUYKQSTNDXRJ-UHFFFAOYSA-N 0.000 claims 1
- WKPYUMZOLALQOY-UHFFFAOYSA-N 5-(1-ethylpyrazol-4-yl)-3-[6-(4-methylpiperazin-1-yl)pyridin-2-yl]-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCN(C)CC2)=N1 WKPYUMZOLALQOY-UHFFFAOYSA-N 0.000 claims 1
- RVDMLVBMTHFTNU-UHFFFAOYSA-N 5-(1-ethylpyrazol-4-yl)-3-[6-(6-fluoro-1,4-diazepan-1-yl)pyridin-2-yl]-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CC(F)CNCC2)=N1 RVDMLVBMTHFTNU-UHFFFAOYSA-N 0.000 claims 1
- GIEVZBXLLKCFDW-CQSZACIVSA-N 5-(1-ethylpyrazol-4-yl)-3-[6-[(3R)-3-methylpiperazin-1-yl]pyridin-2-yl]-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2C[C@@H](C)NCC2)=N1 GIEVZBXLLKCFDW-CQSZACIVSA-N 0.000 claims 1
- OYBHRXWHGRKFFA-UHFFFAOYSA-N 5-(1-ethylpyrazol-4-yl)-3-[6-[3-(trifluoromethyl)piperazin-1-yl]pyridin-2-yl]-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CC(NCC2)C(F)(F)F)=N1 OYBHRXWHGRKFFA-UHFFFAOYSA-N 0.000 claims 1
- BWJJFTLXLCDZOH-UHFFFAOYSA-N 5-(1-ethylpyrazol-4-yl)-3-[6-[4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCN(CC2)C2COC2)=N1 BWJJFTLXLCDZOH-UHFFFAOYSA-N 0.000 claims 1
- CNLSVCKBBPDJDM-UHFFFAOYSA-N 5-(1-methylpyrazol-4-yl)-3-(2-piperazin-1-ylpyrimidin-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=NC(N2CCNCC2)=N1 CNLSVCKBBPDJDM-UHFFFAOYSA-N 0.000 claims 1
- ORMFVHRDHCRBQI-UHFFFAOYSA-N 5-(1-methylpyrazol-4-yl)-3-(2-piperidin-1-ylpyrimidin-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=NC(N2CCCCC2)=N1 ORMFVHRDHCRBQI-UHFFFAOYSA-N 0.000 claims 1
- CDRIATLSWATULL-UHFFFAOYSA-N 5-(1-methylpyrazol-4-yl)-3-(2-piperidin-4-ylpyrimidin-4-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=NC(C2CCNCC2)=N1 CDRIATLSWATULL-UHFFFAOYSA-N 0.000 claims 1
- MRKJDGHXBQFLPE-UHFFFAOYSA-N 5-(1-tert-butylpyrazol-4-yl)-3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(C(C)(C)C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCNCC2)=N1 MRKJDGHXBQFLPE-UHFFFAOYSA-N 0.000 claims 1
- HWAQNGBXVSEQHM-UHFFFAOYSA-N 5-(5-methylpyridin-3-yl)-3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound CC1=CN=CC(C=2N=CC=3NN=C(C=3C=2)C=2N=C(C=CC=2)N2CCNCC2)=C1 HWAQNGBXVSEQHM-UHFFFAOYSA-N 0.000 claims 1
- ZOSLKSUUFDWSAA-UHFFFAOYSA-N 5-(5-methylsulfonylpyridin-3-yl)-3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound CS(=O)(=O)C1=CN=CC(C=2N=CC=3NN=C(C=3C=2)C=2N=C(C=CC=2)N2CCNCC2)=C1 ZOSLKSUUFDWSAA-UHFFFAOYSA-N 0.000 claims 1
- BINWPFGNFSEKRS-UHFFFAOYSA-N 5-(6-fluoropyridin-3-yl)-3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NC(F)=CC=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCNCC2)=N1 BINWPFGNFSEKRS-UHFFFAOYSA-N 0.000 claims 1
- DXFVPMMMQNXSOZ-UHFFFAOYSA-N 5-(6-methylpyrazin-2-yl)-3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound CC1=CN=CC(C=2N=CC=3NN=C(C=3C=2)C=2N=C(C=CC=2)N2CCNCC2)=N1 DXFVPMMMQNXSOZ-UHFFFAOYSA-N 0.000 claims 1
- JCWTUEMNZDIYOV-UHFFFAOYSA-N 5-[1-(2-fluoroethyl)pyrazol-4-yl]-3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CCF)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCNCC2)=N1 JCWTUEMNZDIYOV-UHFFFAOYSA-N 0.000 claims 1
- NXUDAQNZZZTJRO-UHFFFAOYSA-N 5-[1-(2-fluoroethyl)pyrazol-4-yl]-3-[6-(3-methylpiperazin-1-yl)pyridin-2-yl]-1H-pyrazolo[3,4-c]pyridine Chemical compound C1CNC(C)CN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C2=CN(CCF)N=C2)=N1 NXUDAQNZZZTJRO-UHFFFAOYSA-N 0.000 claims 1
- NXUDAQNZZZTJRO-AWEZNQCLSA-N 5-[1-(2-fluoroethyl)pyrazol-4-yl]-3-[6-[(3S)-3-methylpiperazin-1-yl]pyridin-2-yl]-1H-pyrazolo[3,4-c]pyridine Chemical compound C1CN[C@@H](C)CN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C2=CN(CCF)N=C2)=N1 NXUDAQNZZZTJRO-AWEZNQCLSA-N 0.000 claims 1
- IHUDNVZNMZPTNU-UHFFFAOYSA-N 5-[1-(2-methoxyethyl)pyrazol-4-yl]-3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CCOC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCNCC2)=N1 IHUDNVZNMZPTNU-UHFFFAOYSA-N 0.000 claims 1
- OLCCBUVPXPKAKC-UHFFFAOYSA-N 5-[1-(2-methylpropyl)pyrazol-4-yl]-3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=NN(CC(C)C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCNCC2)=N1 OLCCBUVPXPKAKC-UHFFFAOYSA-N 0.000 claims 1
- REZOXLPEJRXIEV-UHFFFAOYSA-N 5-[1-(cyclopropylmethyl)pyrazol-4-yl]-3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=C(C=2N=CC=3NN=C(C=3C=2)C=2N=C(C=CC=2)N2CCNCC2)C=NN1CC1CC1 REZOXLPEJRXIEV-UHFFFAOYSA-N 0.000 claims 1
- GBKPXQXNHPVXSO-UHFFFAOYSA-N 5-[1-(oxetan-3-ylmethyl)pyrazol-4-yl]-3-(6-piperazin-1-ylpyridin-2-yl)-1H-pyrazolo[3,4-c]pyridine Chemical compound C1=C(C=2N=CC=3NN=C(C=3C=2)C=2N=C(C=CC=2)N2CCNCC2)C=NN1CC1COC1 GBKPXQXNHPVXSO-UHFFFAOYSA-N 0.000 claims 1
- RZHKFUHFPSNNES-UHFFFAOYSA-N 6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]-N-(piperidin-4-ylmethyl)pyridin-2-amine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(NCC2CCNCC2)=N1 RZHKFUHFPSNNES-UHFFFAOYSA-N 0.000 claims 1
- CXLUPXYBLQPJNM-UHFFFAOYSA-N 6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]-N-piperidin-4-ylpyridin-2-amine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(NC2CCNCC2)=N1 CXLUPXYBLQPJNM-UHFFFAOYSA-N 0.000 claims 1
- RFKBSKCYQQQCCA-UHFFFAOYSA-N C1(CCC1)C(=O)NCN1C(C=CC(=C1)C1=NNC2=CN=C(C=C21)C=1C=NN(C=1)CC)=O Chemical compound C1(CCC1)C(=O)NCN1C(C=CC(=C1)C1=NNC2=CN=C(C=C21)C=1C=NN(C=1)CC)=O RFKBSKCYQQQCCA-UHFFFAOYSA-N 0.000 claims 1
- CJBMQHNUZIPXPE-UHFFFAOYSA-N CN1N=CC(=C1)C=1C=C2C(=CN=1)NN=C2C=1C=NN(C=1)CC(C)O Chemical compound CN1N=CC(=C1)C=1C=C2C(=CN=1)NN=C2C=1C=NN(C=1)CC(C)O CJBMQHNUZIPXPE-UHFFFAOYSA-N 0.000 claims 1
- CJOMMHUWNAWTKO-UHFFFAOYSA-N N-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]azepan-3-amine Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(NC2CNCCCC2)=N1 CJOMMHUWNAWTKO-UHFFFAOYSA-N 0.000 claims 1
- KEVXHZAFOJCGED-UHFFFAOYSA-N N-[[5-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]-2-oxopyridin-1-yl]methyl]cyclopropanecarboxamide Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CN(CNC(=O)C2CC2)C(=O)C=C1 KEVXHZAFOJCGED-UHFFFAOYSA-N 0.000 claims 1
- IVUSSXITOFZAHC-UHFFFAOYSA-N N1=CC(=CC=C1)C=1C=C2C(=CN=1)NN=C2C1=CC=CC(=N1)N1CC(CCC1)C(C)N Chemical compound N1=CC(=CC=C1)C=1C=C2C(=CN=1)NN=C2C1=CC=CC(=N1)N1CC(CCC1)C(C)N IVUSSXITOFZAHC-UHFFFAOYSA-N 0.000 claims 1
- OAFGYLXZSSMPQW-CQSZACIVSA-N [(3R)-1-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]pyrrolidin-3-yl]methanamine Chemical compound C1[C@@H](CN)CCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=N1 OAFGYLXZSSMPQW-CQSZACIVSA-N 0.000 claims 1
- ZNVUMRSQGFRLPG-HNNXBMFYSA-N [(3S)-1-[3-[3-(2-fluorophenyl)-1H-pyrazolo[3,4-c]pyridin-5-yl]pyridin-4-yl]piperidin-3-yl]methanamine Chemical compound C1[C@H](CN)CCCN1C1=CC=NC=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC=C1F ZNVUMRSQGFRLPG-HNNXBMFYSA-N 0.000 claims 1
- OAFGYLXZSSMPQW-AWEZNQCLSA-N [(3S)-1-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]pyrrolidin-3-yl]methanamine Chemical compound C1[C@H](CN)CCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=N1 OAFGYLXZSSMPQW-AWEZNQCLSA-N 0.000 claims 1
- NZMLZXLTEJFRJC-UHFFFAOYSA-N [1-[5-[3-(2-fluorophenyl)-1H-pyrazolo[3,4-c]pyridin-5-yl]pyridin-3-yl]piperidin-4-yl]methanamine Chemical compound C1CC(CN)CCN1C1=CN=CC(C=2N=CC=3NN=C(C=3C=2)C=2C(=CC=CC=2)F)=C1 NZMLZXLTEJFRJC-UHFFFAOYSA-N 0.000 claims 1
- VUCWPIZXOBOQHY-UHFFFAOYSA-N [1-[6-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl]piperidin-2-yl]methanamine Chemical compound NCC1CCCCN1C1=CC=CC(C=2C3=CC(=NC=C3NN=2)C=2C=NC=CC=2)=N1 VUCWPIZXOBOQHY-UHFFFAOYSA-N 0.000 claims 1
- QVACRZZJGYNCTJ-UHFFFAOYSA-N [1-[6-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperidin-4-yl]methanamine Chemical compound C1=NN(C)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CCC(CN)CC2)=N1 QVACRZZJGYNCTJ-UHFFFAOYSA-N 0.000 claims 1
- WIEHZVMDFOUDQS-UHFFFAOYSA-N [4-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]pyridin-2-yl]piperazin-2-yl]methanol Chemical compound C1=NN(CC)C=C1C(N=C1)=CC2=C1NN=C2C1=CC=CC(N2CC(CO)NCC2)=N1 WIEHZVMDFOUDQS-UHFFFAOYSA-N 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- WJUBYASTGWKFHK-UHFFFAOYSA-N azepan-3-amine Chemical compound NC1CCCCNC1 WJUBYASTGWKFHK-UHFFFAOYSA-N 0.000 claims 1
- 125000004567 azetidin-3-yl group Chemical group N1CC(C1)* 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 230000001404 mediated Effects 0.000 claims 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 8
- 102100000129 CHURC1 Human genes 0.000 description 8
- 101710014631 CHURC1 Proteins 0.000 description 8
- 0 *c(c1c2)n[n]c1cnc2-c1cnccc1 Chemical compound *c(c1c2)n[n]c1cnc2-c1cnccc1 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161522857P | 2011-08-12 | 2011-08-12 | |
| US61/522,857 | 2011-08-12 | ||
| PCT/EP2012/065643 WO2013024002A1 (en) | 2011-08-12 | 2012-08-10 | PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014521711A JP2014521711A (ja) | 2014-08-28 |
| JP2014521711A5 true JP2014521711A5 (pt-PT) | 2016-09-15 |
| JP6133291B2 JP6133291B2 (ja) | 2017-05-24 |
Family
ID=46717823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014524387A Expired - Fee Related JP6133291B2 (ja) | 2011-08-12 | 2012-08-10 | ピラゾロ［３，４−ｃ］ピリジン化合物と使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9260425B2 (pt-PT) |
| EP (1) | EP2742046A1 (pt-PT) |
| JP (1) | JP6133291B2 (pt-PT) |
| KR (1) | KR20140071361A (pt-PT) |
| CN (1) | CN103874700B (pt-PT) |
| BR (1) | BR112014003296A2 (pt-PT) |
| CA (1) | CA2838784A1 (pt-PT) |
| MX (1) | MX355852B (pt-PT) |
| RU (1) | RU2638116C2 (pt-PT) |
| WO (1) | WO2013024002A1 (pt-PT) |
Families Citing this family (93)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
| CN103929963A (zh) | 2011-09-14 | 2014-07-16 | 萨穆梅德有限公司 | 吲唑-3-羧酰胺及其作为WNT/β-CATENIN信号传导通路抑制剂的用途 |
| PH12017500997A1 (en) | 2012-04-04 | 2018-02-19 | Samumed Llc | Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| SG11201408238WA (en) | 2012-06-13 | 2015-01-29 | Incyte Corp | Substituted tricyclic compounds as fgfr inhibitors |
| JP6242885B2 (ja) * | 2012-06-27 | 2017-12-06 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | ５−アザインダゾール化合物及び使用方法 |
| US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
| US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
| CN105120862A (zh) | 2013-01-08 | 2015-12-02 | 萨穆梅德有限公司 | Wnt信号途径的3-(苯并咪唑-2-基)-吲唑抑制剂及其治疗应用 |
| JP6437452B2 (ja) | 2013-01-14 | 2018-12-12 | インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ | Ｐｉｍキナーゼ阻害剤として有用な二環式芳香族カルボキサミド化合物 |
| MX2015009057A (es) | 2013-01-15 | 2015-10-05 | Incyte Corp | Compuestos de tiazolcarboxamidas y piridinacarboxamida utiles como inhibidores de cinasa pim. |
| EA035095B1 (ru) | 2013-04-19 | 2020-04-27 | Инсайт Холдингс Корпорейшн | Бициклические гетероциклы в качестве ингибиторов fgfr |
| WO2015026683A1 (en) * | 2013-08-22 | 2015-02-26 | Merck Sharp & Dohme Corp. | Compounds inhibiting leucine-rich repeat kinase enzyme activity |
| TW201605866A (zh) | 2013-08-23 | 2016-02-16 | 英塞特公司 | 可用作ｐｉｍ激酶抑制劑之呋喃并－及噻吩并－吡啶甲醯胺化合物 |
| US9580418B2 (en) | 2014-07-14 | 2017-02-28 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
| US9822124B2 (en) | 2014-07-14 | 2017-11-21 | Incyte Corporation | Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors |
| WO2016040190A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof |
| WO2016040184A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
| WO2016040181A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
| WO2016040193A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof |
| WO2016040185A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof |
| WO2016040180A1 (en) | 2014-09-08 | 2016-03-17 | Samumed, Llc | 3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof |
| US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| WO2016065587A1 (en) | 2014-10-30 | 2016-05-06 | Merck Sharp & Dohme Corp. | Pyrazole orexin receptor antagonists |
| WO2016095088A1 (en) | 2014-12-15 | 2016-06-23 | Merck Sharp & Dohme Corp. | Erk inhibitors |
| WO2016095089A1 (en) * | 2014-12-15 | 2016-06-23 | Merck Sharp & Dohme Corp. | Erk inhibitors |
| US9580423B2 (en) | 2015-02-20 | 2017-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| CR20170390A (es) | 2015-02-20 | 2017-10-23 | Incyte Holdings Corp | Heterociclos biciclicos como inhibidores de fgfr |
| US9540347B2 (en) | 2015-05-29 | 2017-01-10 | Incyte Corporation | Pyridineamine compounds useful as Pim kinase inhibitors |
| GB201511382D0 (en) | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
| US10285983B2 (en) | 2015-08-03 | 2019-05-14 | Samumed, Llc | 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-B] pyridines and therapeutic uses thereof |
| WO2017023988A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
| US10285982B2 (en) * | 2015-08-03 | 2019-05-14 | Samumed, Llc | 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof |
| US10206908B2 (en) * | 2015-08-03 | 2019-02-19 | Samumed, Llc | 3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof |
| US10226453B2 (en) | 2015-08-03 | 2019-03-12 | Samumed, Llc | 3-(1H-indol-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
| US10231956B2 (en) | 2015-08-03 | 2019-03-19 | Samumed, Llc | 3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
| WO2017024010A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof |
| WO2017024025A1 (en) | 2015-08-03 | 2017-02-09 | Sunil Kumar Kc | 3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
| WO2017023972A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
| WO2017023987A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| WO2017023975A1 (en) * | 2015-08-03 | 2017-02-09 | Samumed, Llc. | 3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof |
| US10604512B2 (en) | 2015-08-03 | 2020-03-31 | Samumed, Llc | 3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof |
| US10166218B2 (en) | 2015-08-03 | 2019-01-01 | Samumed, Llc | 3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof |
| US10392383B2 (en) | 2015-08-03 | 2019-08-27 | Samumed, Llc | 3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof |
| US10329309B2 (en) | 2015-08-03 | 2019-06-25 | Samumed, Llc | 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
| US10206909B2 (en) | 2015-08-03 | 2019-02-19 | Samumed, Llc | 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof |
| WO2017024021A1 (en) | 2015-08-03 | 2017-02-09 | Samumed, Llc | 3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof |
| AR105967A1 (es) | 2015-09-09 | 2017-11-29 | Incyte Corp | Sales de un inhibidor de pim quinasa |
| WO2017045955A1 (en) * | 2015-09-14 | 2017-03-23 | Basf Se | Heterobicyclic compounds |
| WO2017059251A1 (en) | 2015-10-02 | 2017-04-06 | Incyte Corporation | Heterocyclic compounds useful as pim kinase inhibitors |
| CN105213391B (zh) * | 2015-10-19 | 2018-05-18 | 青岛市中心医院 | 一种治疗肝癌的药物组合物及其应用 |
| EP3370721A4 (en) | 2015-11-06 | 2019-05-22 | Samumed, LLC | TREATMENT OF OSTEOARTHRITIS |
| HUE060797T2 (hu) | 2016-06-01 | 2023-04-28 | Biosplice Therapeutics Inc | Eljárás N-(5-(3-(7-(3-fluorfenil)-3H-imidazo[4,5-c]piridin-2-il)-1H-indazol-5-il)- piridin-3-il)-3-metilbutánamid elõállítására |
| AR109596A1 (es) * | 2016-09-09 | 2018-12-26 | Incyte Corp | Compuestos pirazolopiridina y sus usos |
| WO2018049191A1 (en) | 2016-09-09 | 2018-03-15 | Incyte Corporation | Pyrazolopyridone derivatives as hpk1 modulators and uses thereof for the treatment of cancer |
| TW201811799A (zh) | 2016-09-09 | 2018-04-01 | 美商英塞特公司 | 吡唑并嘧啶化合物及其用途 |
| WO2018049214A1 (en) | 2016-09-09 | 2018-03-15 | Incyte Corporation | Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer |
| EP3528808B1 (en) | 2016-10-21 | 2021-10-06 | BioSplice Therapeutics, Inc. | Methods of using indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors |
| WO2018085865A1 (en) | 2016-11-07 | 2018-05-11 | Samumed, Llc | Single-dose, ready-to-use injectable formulations |
| US20180228786A1 (en) * | 2017-02-15 | 2018-08-16 | Incyte Corporation | Pyrazolopyridine compounds and uses thereof |
| AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
| US11242334B2 (en) | 2017-08-22 | 2022-02-08 | Js Innopharm (Shanghai) Ltd. | Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof |
| US10722495B2 (en) | 2017-09-08 | 2020-07-28 | Incyte Corporation | Cyanoindazole compounds and uses thereof |
| JP7250011B2 (ja) * | 2017-10-27 | 2023-03-31 | バイエル アクチェンゲゼルシャフト | Ｐ２ｘ３阻害剤としての新規なピラゾロ－ピロロ－ピリミジン－ジオン誘導体 |
| AR113922A1 (es) | 2017-12-08 | 2020-07-01 | Incyte Corp | Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas |
| WO2019164847A1 (en) | 2018-02-20 | 2019-08-29 | Incyte Corporation | Indazole compounds and uses thereof |
| MD3755703T2 (ro) | 2018-02-20 | 2022-10-31 | Incyte Corp | Derivați N-(fenil)-2-(fenil)pirimidin-4-carboxamidă și compuși înrudiți ca inhibitori HPK1 pentru tratarea cancerului |
| US10745388B2 (en) | 2018-02-20 | 2020-08-18 | Incyte Corporation | Indazole compounds and uses thereof |
| UY38144A (es) | 2018-03-12 | 2019-10-31 | Abbvie Inc | Inhibidores de la señalización mediada por tirosina cinasa |
| US11299473B2 (en) | 2018-04-13 | 2022-04-12 | Incyte Corporation | Benzimidazole and indole compounds and uses thereof |
| WO2019213506A1 (en) | 2018-05-04 | 2019-11-07 | Incyte Corporation | Salts of an fgfr inhibitor |
| SG11202010636VA (en) | 2018-05-04 | 2020-11-27 | Incyte Corp | Solid forms of an fgfr inhibitor and processes for preparing the same |
| US10899755B2 (en) | 2018-08-08 | 2021-01-26 | Incyte Corporation | Benzothiazole compounds and uses thereof |
| TW202028207A (zh) | 2018-09-25 | 2020-08-01 | 美商英塞特公司 | 吡唑并嘧啶化合物及其用途 |
| US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
| CN110201719B (zh) * | 2019-06-06 | 2020-04-21 | 南京科技职业学院 | 一种制药污水治理方法 |
| CN112142744A (zh) * | 2019-06-28 | 2020-12-29 | 上海瑛派药业有限公司 | 取代的稠合杂芳双环化合物作为激酶抑制剂及其应用 |
| WO2021007269A1 (en) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| KR20220059480A (ko) | 2019-08-06 | 2022-05-10 | 인사이트 코포레이션 | 고체 형태의 hpk1 억제제 |
| CR20220169A (es) | 2019-10-14 | 2022-10-27 | Incyte Corp | Heterociclos bicíclicos como inhibidores de fgfr |
| WO2021076728A1 (en) | 2019-10-16 | 2021-04-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| JP2023505258A (ja) | 2019-12-04 | 2023-02-08 | インサイト・コーポレイション | Ｆｇｆｒ阻害剤としての三環式複素環 |
| CA3162010A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Derivatives of an fgfr inhibitor |
| US11193891B2 (en) | 2019-12-20 | 2021-12-07 | Robert Bosch Gmbh | Receptors and spacers for a fluorescence-based lead ion chemosensor |
| US12012409B2 (en) | 2020-01-15 | 2024-06-18 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| KR20230039675A (ko) * | 2020-07-13 | 2023-03-21 | 베이징 타이드 파마슈티컬 코퍼레이션 리미티드 | Atr 키나제 억제제로 사용되는 피라졸로피리미딘 화합물 |
| CA3220274A1 (en) | 2021-06-09 | 2022-12-15 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| WO2024029583A1 (ja) * | 2022-08-05 | 2024-02-08 | 国立研究開発法人理化学研究所 | 新規ピラゾール誘導体及びその用途 |
| US11976079B1 (en) | 2023-12-15 | 2024-05-07 | King Faisal University | Pyrazino[1′,2′:1,5]pyrazolo[4,3-b][1,6]naphthyridines compounds as CK2 inhibitors |
| US11987581B1 (en) | 2023-12-19 | 2024-05-21 | King Faisal University | Imidazo[1,2-c]pyrido[3,4-e]pyrimidine-2-carboxylic acids as CK2 inhibitors |
| US12024518B1 (en) | 2023-12-20 | 2024-07-02 | King Faisal University | Pyrazolo[4,3-C][1,6]naphthyridines as CK2 inhibitors |
| US11964974B1 (en) | 2024-01-08 | 2024-04-23 | King Faisal University | Imidazo[1,2-c]pyrido[3,4-e]pyrimidine-3-carboxylic acids as CK2 inhibitors |
| US11981676B1 (en) | 2024-01-16 | 2024-05-14 | King Faisal University | Pyrazolo[4,3-c][2,6]naphthyridines as CK2 inhibitors |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US5543523A (en) | 1994-11-15 | 1996-08-06 | Regents Of The University Of Minnesota | Method and intermediates for the synthesis of korupensamines |
| GB9423460D0 (en) | 1994-11-21 | 1995-01-11 | Merck Sharp & Dohme | Therapeutic agents |
| PT1309592E (pt) | 2000-08-14 | 2006-07-31 | Ortho Mcneil Pharm Inc | Pirazoles substituidos |
| NZ524682A (en) | 2000-09-06 | 2004-11-26 | Ortho Mcneil Pharm Inc | A method for treating allergies using substituted pyrazoles |
| WO2003101968A1 (fr) * | 2002-05-31 | 2003-12-11 | Eisai Co., Ltd. | Compose de pyrazole et composition medicinale le contenant |
| WO2006042102A2 (en) | 2004-10-05 | 2006-04-20 | Neurogen Corporation | Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds |
| PE20061119A1 (es) * | 2005-01-19 | 2006-11-27 | Aventis Pharma Sa | PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie |
| JP5129143B2 (ja) | 2005-10-07 | 2013-01-23 | エグゼリクシス， インコーポレイテッド | Ｍｅｋインヒビターおよびその使用方法 |
| JP5357763B2 (ja) * | 2006-11-06 | 2013-12-04 | トレロ ファーマシューティカルズ， インコーポレイテッド | イミダゾ［１，２−ｂ］ピリダジン誘導体およびピラゾロ［１，５−ａ］ピリダジン誘導体およびプロテインキナーゼインヒビターとしてのこれらの使用 |
| CN101790526A (zh) * | 2007-06-08 | 2010-07-28 | 雅培制药有限公司 | 用作激酶抑制剂的5-杂芳基取代的吲唑化合物 |
| EP2217601A1 (en) * | 2007-11-08 | 2010-08-18 | Centro Nacional de Investigaciones Oncológicas (CNIO) | Imidazopyridazines for use as protein kinase inhibitors |
| KR100906571B1 (ko) * | 2008-06-29 | 2009-07-06 | 한창섭 | 광소자를 이용한 반구형 포인팅 장치 |
| WO2010022081A1 (en) * | 2008-08-19 | 2010-02-25 | Array Biopharma Inc. | Triazolopyridine compounds as pim kinase inhibitors |
| EP2649065A1 (en) * | 2010-12-09 | 2013-10-16 | Amgen Inc. | Bicyclic compounds as pim inhibitors |
-
2012
- 2012-08-10 EP EP12748670.2A patent/EP2742046A1/en not_active Withdrawn
- 2012-08-10 KR KR1020147006423A patent/KR20140071361A/ko active IP Right Grant
- 2012-08-10 JP JP2014524387A patent/JP6133291B2/ja not_active Expired - Fee Related
- 2012-08-10 MX MX2014001239A patent/MX355852B/es active IP Right Grant
- 2012-08-10 US US13/571,595 patent/US9260425B2/en not_active Expired - Fee Related
- 2012-08-10 WO PCT/EP2012/065643 patent/WO2013024002A1/en active Application Filing
- 2012-08-10 CA CA2838784A patent/CA2838784A1/en not_active Abandoned
- 2012-08-10 CN CN201280050370.5A patent/CN103874700B/zh not_active Expired - Fee Related
- 2012-08-10 RU RU2014106966A patent/RU2638116C2/ru not_active IP Right Cessation
- 2012-08-10 BR BR112014003296A patent/BR112014003296A2/pt not_active Application Discontinuation
-
2016
- 2016-02-16 US US15/044,231 patent/US9850239B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014521711A5 (pt-PT) | ||
| US11912703B2 (en) | 6-azaindole compounds | |
| JP5823518B2 (ja) | ブルトン型チロシンキナーゼの阻害剤 | |
| RU2473549C2 (ru) | Пиримидиновые соединения, композиции и способы применения | |
| TWI481608B (zh) | 作為ｊａｋ抑制劑之咪唑並吡啶衍生物 | |
| JP6401709B2 (ja) | Ａｔｒキナーゼ阻害剤として有用な化合物 | |
| KR101677778B1 (ko) | 아미노피라진 유도체 및 의약 | |
| JP5933902B2 (ja) | Ｔｒｋａキナーゼ阻害剤としてのピロリジニル尿素およびピロリジニルチオ尿素化合物 | |
| JP7382938B2 (ja) | ジアザインドール化合物 | |
| US20200172546A1 (en) | Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors | |
| WO2019126253A1 (en) | Aryl and heteroaryl substituted indole compounds | |
| CA2857302C (en) | Use of inhibitors of the activity or function of pi3k | |
| US8623857B2 (en) | N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1 | |
| RU2017134901A (ru) | Соединения 1-циано-пирролидинов в качестве ингибиторов USP30 | |
| JP2015500332A5 (pt-PT) | ||
| RU2013124101A (ru) | Гетероциклические амины и их применения | |
| JP2017530960A5 (pt-PT) | ||
| JP2018500376A5 (pt-PT) | ||
| JP2018522046A5 (pt-PT) | ||
| JP2012525395A5 (pt-PT) | ||
| CA2671744A1 (en) | Compounds and compositions as protein kinase inhibitors | |
| CA2798622A1 (en) | Indoles | |
| JP2016500671A5 (pt-PT) | ||
| JP2012528828A5 (pt-PT) | ||
| RU2014149684A (ru) | Производные аминохиназолина и пиридопиримидина |